Posted on: 26 August, 2024
Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer.
The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the cancer.
The Howlett family has welcomed the research .....
Read more
Category: Funding support, Research Excellence
Posted on: 22 August, 2024
Researchers at the Kolling Institute have welcomed the launch of Australia's premier cancer clinical trials centre on the Royal North Shore Hospital campus.
NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.
The centre is a ground-breaking partnership between Northern Sydney Local .....
Read more
Category: Funding support, New Treatment, Research Excellence
Posted on: 15 August, 2024
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy.
The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work.
His talented team of seven .....
Read more
Category: Neuroscience and Pain Research, Research Excellence, World-leading technology
Posted on: 12 August, 2024
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory.
Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s estimated up to 125 million people will have the con.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 07 August, 2024
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute.
Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders.
Our teams have continued to increase their research impact, while forging.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 05 August, 2024
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team.
The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia.
This form of blood cancer is particularly aggressive, with less .....
Read more
Category: Funding support, Research Excellence
Posted on: 31 July, 2024
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury.
The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more
Category: Neuroscience and Pain Research, Research Excellence
Posted on: 05 July, 2024
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes.
The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due to peripheral arterial disease.
Alarmingly, an estimated eight p.....
Read more
Category: Research Excellence
Posted on: 01 July, 2024
While there has been a great deal of encouraging progress with many cancer treatments over the last decade, the prognosis for people with acute myeloid leukaemia remains dismal, with only 27 per cent of patients surviving more than five years after treatment.
Lead researcher Dr Jenny Wang said we have seen a sharp rise in the number of people with the deadly form of blood cancer in recent years and.....
Read more
Category: Funding support, Research Excellence
Posted on: 24 June, 2024
It is with great sadness that the Kolling Institute acknowledges the passing of Professor John Walsh AO.
Professor Walsh had a longstanding relationship with many researchers across the Kolling and the local health district and was immensely respected by his colleagues.
Having a background as an actuary, Professor Walsh applied his expertise to many projects over his life, specifically policy devel.....
Read more
Category: Research Excellence